PharmaShots | Incisive News in 3 Shots

Subscribe Now

Apexigen

Apexigen Presents Results of Sotigalimab + Pembrolizumab in P-II Trial for the Treatment of Metastatic Melanoma at AACR 2022

Apexigen Presents Results of Sotigalimab + Pembrolizumab in P-II Trial for the Treatment of Metastatic Melanoma at AACR 2022

April 13, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us